NY woman awarded $285K in Fosamax osteonecrosis trial
A 69-year-old New York woman has succeeded in her efforts to hold Merck, makers of the osteoporosis drug Fosamax, accountable for her osteonecrosis of the jaw (ONJ) and related health issues. On February 5, a federal jury ordered Merck to pay Rhoda Scheinberg $285,000 in the case, which was originally filed in 2008 in U.S District Court for the Southern District of New York. The jury found that Merck was

